Details for 2011188373

Up to date per 04.04.2026

Actions

Title / Product Name

4-Benzylamino-1-carboxyacyl-piperidin-Derivate als CETP-Inhibitoren zur Behandlung von Erkrankungen wie Hyperlipidämie oder Arteriosklerose

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2011188373

EP Publication Number

2463282

E-Number

625726

Language

PCT Number

Publication Date

13.06.2012 A

07.08.2013 B1

Registration Date

07.08.2013

AT Publication Date

15.08.2013

Application Date

03.11.2008

Registration Number

Priorities

05.11.2007

985456 P

IPC

C07D 401/12 20060101AFI20130125BHEP

Maximum Duration of Protection

03.11.2028

Owner

Novartis AGLichtstrasse 35 4056 BaselCH

Representative

Schwarz & Partner Patentanwälte OGWipplingerstraße 301010 WienAT

Inventor

Mogi, Muneto70 Hope Avenue, 603 Waltham, MA Massachusetts 02453US

Yamada, Ken4 Emerson Place, 711 Boston, MA Massachusetts 02114US

Yasoshima, Kayoc/o Novartis Institutes for BioMedical Rsrch, Inc. 100 Technology Square Cambridge, MA Massachusetts 02139US

Kawanami, ToshioOne Emerson Place 16L Boston, MA Massachusetts 02114US

Umemura, IchiroPark Hill Azuma 1-401 3-19-1 Azuma Tsukuba-shi, Ibaraki 305-0031JP

Iwaki, Yuki1691 Cambridge Street, 24 Cambridge, MA Massachusetts 02138US

Qin, Hongbo1049-7 Nakanojo Sakakimachi Hanishinagun, Nagano 389-0602JP

Imase, Hidetomo30 Cambridge Park Dr. 4137 Cambridge, MA Massachusetts 02140US